Changes in nitrite and nitrate (NO2/-/NO3/-) levels in cerebrospinal fluid of patients with multiple sclerosis

Journal of the Neurological Sciences

Volumn 153, Issue 1, 1997, Pages 32-34

  Yamashita, Taro ^a   Ando, Yukio ^a   Obayashi, Konen ^a   Uchino, Makoto ^a   Ando, Masayuki ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Activity; Cerebrospinal fluid; Methylpredonisolone; Multiple sclerosis; Nitric oxide synthase; NO2 NO3

Indexed keywords

METHYLPREDNISOLONE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; DISEASE ACTIVITY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADULT; ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; MALE; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS; NITRATES; NITRIC ACID;

EID: 0031443005     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00183-4     Document Type: Article

References (8)

1. Adachi K., Kumamoto T., Araki S. Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis. Ann. Neurol. 28:1990;687-691.
2. Bagasra O., Michaels F.H., Zheng Y.M., Bobroski L.E., Spitsin S.V., Fu Z.F., Tawadros R., Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA. 92:1995;12041-12045.
3. Bo L., Dawson T.M., Wesselingh S., Mork S., Choi S., Kong P.A., Hanley D., Trapp B.D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:1994;778-786.
4. 15N] nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
5. Milstien S., Sakai N., Brew B.J., Krieger C., Vickers J.H., Saito K., Heyes M.P. Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases. J. Neurochem. 63:1994;1178-1180.
6. Panitch H.S., Hirsch R.L., Haley A.S., Johnson K.P. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet. 1:1987;893-895.
7. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
8. Winlaw D.S., Smythe G.A., Keogh A.M., Schyvens C.G., Spratt P.M., Macdonald P.S. Increased nitric oxide production in heart failure. Lancet. 344:1994;373-374.